T. Rowe Price Associates’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,600
| Closed | -$75K | – | 2923 |
|
|
2023
Q1 | $75K | Sell |
25,600
-10,800
| -30% | -$31.6K | ﹤0.01% | 2734 |
|
|
2022
Q4 | $106K | Sell |
36,400
-10,600
| -23% | -$30.9K | ﹤0.01% | 2707 |
|
|
2022
Q3 | $113K | Sell |
47,000
-15,000
| -24% | -$36.1K | ﹤0.01% | 2699 |
|
|
2022
Q2 | $140K | Sell |
62,000
-16,100
| -21% | -$36.4K | ﹤0.01% | 2679 |
|
|
2022
Q1 | $180K | Hold |
78,100
| – | – | ﹤0.01% | 2732 |
|
|
2021
Q4 | $195K | Sell |
78,100
-55,500
| -42% | -$139K | ﹤0.01% | 2763 |
|
|
2021
Q3 | $424K | Buy |
+133,600
| New | +$424K | ﹤0.01% | 2443 |
|